Researchers have created a disposable microfluidic device that can detect 77 protein biomarkers in breast cancer alone, and will likely save time, space and cost in disease detection. "Sample injection, separation, labeling, and detection can be performed routinely in a few minutes ... paving the way for high-throughput testing that will permit screening at the population level for prognostic or diagnostic markers for a whole range of diseases," the lead researcher said.

Related Summaries